Refining precision prognostics in multiple myeloma: loss of miR-221/222 cluster in CD138+ plasma cells results in short-term progression and worse treatment outcome
The persistence of high relapse rates and therapy resistance continues to challenge the effective management of multiple myeloma (MM). The identifi…
